Literature DB >> 23460009

Ecology of nontuberculous mycobacteria--where do human infections come from?

Joseph O Falkinham1.   

Abstract

Nontuberculous mycobacteria (NTM) are environmental, opportunistic human pathogens whose reservoirs include peat-rich potting soil and drinking water in buildings and households. In fact, humans are likely surrounded by NTM. NTM are ideally adapted for residence in drinking water distribution systems and household and building plumbing as they are disinfectant-resistant, surface adherent, and able to grow on low concentrations of organic matter. For individuals at risk for NTM infection, measures can be taken to reduce NTM exposure. These include avoiding inhalation of dusts from peat-rich potting soil and aerosols from showers, hot tubs, and humidifiers. A riskanalysis of the presence of NTM in drinking water has not been initiated because the virulence of independent isolates of even single NTM species (e.g., Mycobacterium avium) is quite broad, and virulence determinants have not been identified. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23460009     DOI: 10.1055/s-0033-1333568

Source DB:  PubMed          Journal:  Semin Respir Crit Care Med        ISSN: 1069-3424            Impact factor:   3.119


  48 in total

Review 1.  Macrophage Signaling Pathways in Pulmonary Nontuberculous Mycobacteria Infections.

Authors:  Zohra Prasla; Roy L Sutliff; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

2.  Differential In Vitro Activities of Individual Drugs and Bedaquiline-Rifabutin Combinations against Actively Multiplying and Nutrient-Starved Mycobacterium abscessus.

Authors:  Jin Lee; Nicole Ammerman; Anusha Agarwal; Maram Naji; Si-Yang Li; Eric Nuermberger
Journal:  Antimicrob Agents Chemother       Date:  2021-01-20       Impact factor: 5.191

Review 3.  Microbiological features and clinical relevance of new species of the genus Mycobacterium.

Authors:  Enrico Tortoli
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

4.  Characterization of Clinical Isolates of Mycobacterium simiae Using Drug Susceptibility Tests and Molecular Analyses.

Authors:  Hoda Dezhkhi; Parissa Farnia; Azam Haddadi; Poopak Farnia; Ali Akbar Velayati
Journal:  Curr Microbiol       Date:  2021-04-13       Impact factor: 2.188

Review 5.  A genetic perspective on granulomatous diseases with an emphasis on mycobacterial infections.

Authors:  Un-In Wu; Steven M Holland
Journal:  Semin Immunopathol       Date:  2016-01-05       Impact factor: 9.623

6.  Isolation of Nontuberculous Mycobacteria from the Environment of Ghanian Communities Where Buruli Ulcer Is Endemic.

Authors:  Samuel Yaw Aboagye; Emelia Danso; Kobina Assan Ampah; Zuliehatu Nakobu; Prince Asare; Isaac Darko Otchere; Katharina Röltgen; Dzidzo Yirenya-Tawiah; Dorothy Yeboah-Manu
Journal:  Appl Environ Microbiol       Date:  2016-06-30       Impact factor: 4.792

7.  Outbreaks due to Mycobacterium abscessus subsp. bolletii in southern Brazil: persistence of a single clone from 2007 to 2011.

Authors:  Luciana de S Nunes; Ludmila F Baethgen; Marta O Ribeiro; Cássia M Cardoso; Fernanda de Paris; Simone M M De David; Marlei G da Silva; Rafael S Duarte; Afonso L Barth
Journal:  J Med Microbiol       Date:  2014-07-18       Impact factor: 2.472

8.  In Vitro Activity of Clofazimine against Nontuberculous Mycobacteria Isolated in Beijing, China.

Authors:  Jingjing Luo; Xia Yu; Guanglu Jiang; Yuhong Fu; Fengmin Huo; Yifeng Ma; Fen Wang; Yuanyuan Shang; Qian Liang; Yi Xue; Hairong Huang
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

9.  Host response to nontuberculous mycobacterial infections of current clinical importance.

Authors:  Ian M Orme; Diane J Ordway
Journal:  Infect Immun       Date:  2014-06-09       Impact factor: 3.441

Review 10.  Nontuberculous mycobacterial pulmonary infections.

Authors:  Margaret M Johnson; John A Odell
Journal:  J Thorac Dis       Date:  2014-03       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.